Share on Facebook Share on Twitter Email
Answers.com

Insulin-like growth factor 2

 
Wikipedia: Insulin-like growth factor 2
edit
Insulin-like growth factor 2 (somatomedin A)
PDB rendering based on 1igl.
Available structures: 1igl
Identifiers
Symbols IGF2; C11orf43; FLJ22066; FLJ44734; INSIGF; pp9974
External IDs OMIM: 147470 MGI96434 HomoloGene510
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 3481 16002
Ensembl ENSG00000167244 ENSMUSG00000048583
Uniprot P01344 P09535
Refseq NM_000612 (mRNA)
NP_000603 (protein)
NM_010514 (mRNA)
NP_034644 (protein)
Location Chr 11: 2.11 - 2.13 Mb Chr 7: 142.46 - 142.47 Mb
Pubmed search [1] [2]

Insulin-like growth factor 2 (IGF-2) is one of three protein hormones that share structural similarity to insulin.

Contents

Gene structure

In humans, the IGF2 gene is located on chromosome 11p15.5, a region which contains numerous imprinted genes. In mice this homologous region is found at distal chromosome 7. In both organisms, Igf2 is imprinted, with expression resulting favourably from the paternally inherited allele.

The protein CTCF is involved in repressing expression of the gene, by binding to the H19 imprinting control region (ICR) along with Differentially-methylated Region-1 (DMR1) and Matrix Attachment Region -3 (MAR3). These three DNA sequences bind to CTCF in a way that limits downstream enhancer access to the Igf2 region. The mechanism in which CTCF binds to these regions is currently unknown, but could include either a direct DNA-CTCF interaction or it could possibly be mediated by other proteins

Protein structure

IGF-2 exerts its effects by binding to the IGF-1 receptor. IGF2 may also bind to the IGF-2 receptor (also called the cation-independent mannose 6-phosphate receptor), which acts as a signalling antagonist; that is, to prevent IGF2 responses.

Function

The major role of IGF2 is as a growth promoting hormone during gestation.

Diseases

It is sometimes produced in non-islet cell tumours, causing hypoglycemia (Doege-Potter syndrome).

See also

Interactions

Insulin-like growth factor 2 has been shown to interact with IGFBP3[1][2][3][4] and Transferrin.[1]

References

  1. ^ a b Storch, S; Kübler B, Höning S, Ackmann M, Zapf J, Blum W, Braulke T (Dec. 2001). "Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3". FEBS Lett. (Netherlands) 509 (3): 395-8. ISSN 0014-5793. PMID 11749962. 
  2. ^ Buckway, C K; Wilson E M, Ahlsén M, Bang P, Oh Y, Rosenfeld R G (Oct. 2001). "Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding". J. Clin. Endocrinol. Metab. (United States) 86 (10): 4943-50. ISSN 0021-972X. PMID 11600567. 
  3. ^ Twigg, S M; Baxter R C (Mar. 1998). "Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit". J. Biol. Chem. (UNITED STATES) 273 (11): 6074-9. ISSN 0021-9258. PMID 9497324. 
  4. ^ Firth, S M; Ganeshprasad U, Baxter R C (Jan. 1998). "Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3". J. Biol. Chem. (UNITED STATES) 273 (5): 2631-8. ISSN 0021-9258. PMID 9446566. 

External links

Further reading



Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
 
 

 

Copyrights:

Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Insulin-like growth factor 2" Read more